pyrroles has been researched along with Neoplasm Metastasis, Unknown Primary in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Golinelli, G; Pia, F; Rosa, MS; Toso, A; Valletti, PA | 1 |
| Imai, H; Kageyama, S; Katayama, N; Matsuoka, N; Mizuno, T; Oda, H; Saito, K; Sugawara, Y; Tamaru, S; Uchida, K; Yamashita, Y | 1 |
| Bai, R; Li, J; Li, Y; Ma, Y; Shi, H; Wang, C; Xiao, J; Xu, W; Yang, C; Yu, H; Zhang, J | 1 |
| Dova, L; Fountzilas, G; Georgiou, I; Golfinopoulos, V; Malamou-Mitsi, V; Ntemou, A; Pavlidis, N; Pentheroudakis, G; Vartholomatos, G | 1 |
1 trial(s) available for pyrroles and Neoplasm Metastasis, Unknown Primary
| Article | Year |
|---|---|
Volume-based predictive biomarkers of sequential FDG-PET/CT for sunitinib in cancer of unknown primary: identification of the best benefited patients.
Topics: Adult; Antineoplastic Agents; Biomarkers; China; Female; Fluorodeoxyglucose F18; Humans; Indoles; Male; Middle Aged; Neoplasms, Unknown Primary; Outcome Assessment, Health Care; Patient Selection; Positron Emission Tomography Computed Tomography; Prevalence; Prognosis; Pyrroles; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Sunitinib; Survival Rate; Treatment Outcome; Tumor Burden | 2017 |
3 other study(ies) available for pyrroles and Neoplasm Metastasis, Unknown Primary
| Article | Year |
|---|---|
Skull Base Metastasis From Occult Renal Cell Carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Combined Modality Therapy; Everolimus; Humans; Immunotherapy; Indoles; Kidney Neoplasms; Male; Neoplasms, Unknown Primary; Nephrectomy; Niacinamide; Phenylurea Compounds; Pyrroles; Skull Base Neoplasms; Sorafenib; Sunitinib | 2018 |
[A case report of a well-differentiated neuroendocrine tumor in which sunitinib treatment resulted in stable disease].
Topics: Antineoplastic Agents; Cell Differentiation; Disease Progression; Female; Humans; Indoles; Middle Aged; Neoplasms, Unknown Primary; Neuroendocrine Tumors; Pyrroles; Sunitinib | 2013 |
Targeting c-KIT, PDGFR in cancer of unknown primary: a screening study for molecular markers of benefit.
Topics: Aged; Aged, 80 and over; Benzamides; Exons; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Immunohistochemistry; Indoles; Male; Middle Aged; Mutation; Neoplasms, Unknown Primary; Piperazines; Polymorphism, Genetic; Prognosis; Proto-Oncogene Proteins c-kit; Pyrimidines; Pyrroles; Receptors, Platelet-Derived Growth Factor; Sunitinib | 2008 |